0
Skip to Content
K2 Health Ventures
Approach
Team
Portfolio
News
Purpose
Contact
K2 Health Ventures
Approach
Team
Portfolio
News
Purpose
Contact
Approach
Team
Portfolio
News
Purpose
Contact

 

Featured
Phil
May 15, 2025
Phil
May 15, 2025

PhilRx combines an integrated digital hub, pharmacy network, and script-level data & insights to help brands take patient outcomes and economic performance to the next level.

May 15, 2025
Neumora Therapeutics
May 14, 2025
Neumora Therapeutics
May 14, 2025

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

May 14, 2025
Sidecar Health
Apr 15, 2025
Sidecar Health
Apr 15, 2025

Sidecar Health insurance plans are based on an intuitive, tech-forward approach that removes obstacles to care and empowers members with the information they need to make smart care decisions.

Apr 15, 2025
Suvida Healthcare
Mar 28, 2025
Suvida Healthcare
Mar 28, 2025

Suvida Healthcare is a multidisciplinary primary care program built to address the physical, behavioral, social, and cultural needs of Medicare-eligible, Hispanic seniors and those that care for them in neighborhoods across the United States.

Mar 28, 2025
Concert Health
Jan 17, 2025
Concert Health
Jan 17, 2025

Concert Health provides a turnkey solution to integrate behavioral health into primary health care settings like primary care, women’s health and pediatric offices.

Jan 17, 2025
Umoja Biopharma
Jan 15, 2025
Umoja Biopharma
Jan 15, 2025

Clinical-stage biotechnology company aiming to develop in vivo cell therapies that improve the reach, effectiveness, and access of CAR T cell therapies in both oncology and autoimmunity.

Jan 15, 2025
Evergreen Nephrology
Dec 23, 2024
Evergreen Nephrology
Dec 23, 2024

In collaboration with nephrologist and payer partners, Evergreen focuses on fostering a holistic-care experience for individuals living with chronic kidney disease and end-stage kidney disease.

Dec 23, 2024
Orthofix (NASDAQ:OFIX)
Nov 11, 2024
Orthofix (NASDAQ:OFIX)
Nov 11, 2024

Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system.

Nov 11, 2024
Werewolf Therapeutics (NASDAQ: HOWL)
May 9, 2024
Werewolf Therapeutics (NASDAQ: HOWL)
May 9, 2024

Clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer and other immune-mediated conditions.

May 9, 2024
HarmonyCares
Apr 4, 2024
HarmonyCares
Apr 4, 2024

Value-based care provider delivering comprehensive, home-based primary care services.

Apr 4, 2024
Infusion for Health
Feb 29, 2024
Infusion for Health
Feb 29, 2024

Comprehensive infusion therapy services delivering safe, private, and convenient care for the most enjoyable patient experience.

Feb 29, 2024
Acumen Pharmaceuticals (NASDAQ: ABOS)
Nov 13, 2023
Acumen Pharmaceuticals (NASDAQ: ABOS)
Nov 13, 2023

Clinical-stage drug development company focused on developing novel targeted therapies for Alzheimer's disease.

Nov 13, 2023
Longevity
Oct 19, 2023
Longevity
Oct 19, 2023

A clinical services company and national Institutional Special Needs (ISNP) plan dedicated to serving individuals in senior living settings.

Oct 19, 2023
MindMed (NASDAQ: MNMD)
Aug 14, 2023
MindMed (NASDAQ: MNMD)
Aug 14, 2023

Clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders.

Aug 14, 2023
Fuze Health
Jun 30, 2023
Fuze Health
Jun 30, 2023

Fuze Health is a technology-powered home health screening, genomics and pharmacy services provider committed to transforming patient experiences and enabling its healthcare partners.

Jun 30, 2023
Spark Pediatrics
Jun 30, 2023
Spark Pediatrics
Jun 30, 2023

Provider of pediatric medical daycares staffed by specialized nurses and aides, creating a safe space for children with medical complexities to socialize while receiving skilled care.

Jun 30, 2023
Vedanta Biosciences
Apr 25, 2023
Vedanta Biosciences
Apr 25, 2023

A clinical-stage company developing a potential new category of oral therapies based on defined bacterial consortia.

Apr 25, 2023
Harpoon Therapeutics (NASDAQ: HARP)
Mar 27, 2023
Harpoon Therapeutics (NASDAQ: HARP)
Mar 27, 2023

Clinical-stage immuno-oncology company developing a novel class of T cell engagers that unleash the natural power of the T cells to fight cancer and other diseases.

Mar 27, 2023
Alignment Health (NASDAQ: ALHC)
Feb 2, 2023
Alignment Health (NASDAQ: ALHC)
Feb 2, 2023

Tech-enabled Medicare Advantage company that partners with local providers to deliver high-quality, low-cost coordinated care.

Feb 2, 2023
89bio (NASDAQ: ETNB)
Jan 4, 2023
89bio (NASDAQ: ETNB)
Jan 4, 2023

Clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.

Jan 4, 2023
Alto Neuroscience (NYSE: ANRO)
Dec 22, 2022
Alto Neuroscience (NYSE: ANRO)
Dec 22, 2022

Clinical-stage drug development company pioneering precision psychiatry by developing targeted medicines to help patients get better faster.

Dec 22, 2022
OncXerna Therapeutics
Dec 20, 2022
OncXerna Therapeutics
Dec 20, 2022

Clinical-stage precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its targeted oncology therapeutic candidates.

Dec 20, 2022
DispatchHealth
Nov 16, 2022
DispatchHealth
Nov 16, 2022

A comprehensive in-home, high acuity medical care provider bringing the power of the hospital to the comfort of the home.

Nov 16, 2022
Aptinyx (NASDAQ: APTX)
Nov 11, 2022
Aptinyx (NASDAQ: APTX)
Nov 11, 2022

Clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders.

Nov 11, 2022
ASLAN Pharmaceuticals (NASDAQ: ASLN)
Nov 10, 2022
ASLAN Pharmaceuticals (NASDAQ: ASLN)
Nov 10, 2022

Clinical-stage immunology focused biopharmaceutical company developing therapies for atopic dermatitis and asthma.

Nov 10, 2022
Click Therapeutics
Nov 10, 2022
Click Therapeutics
Nov 10, 2022

A Digital Therapeutics™ Company pioneering software solutions as prescription medical treatments.

Nov 10, 2022
Colorescience
Nov 10, 2022
Colorescience
Nov 10, 2022

Cosmeceutical company providing natural, mineral-based approach to skin protection and skin health.

Nov 10, 2022
Companion Medical
Nov 10, 2022
Companion Medical
Nov 10, 2022

Innovative diabetes-focused medical device company that developed the first and only FDA-cleared smart insulin pen and app system.

Nov 10, 2022
Corbus Pharmaceuticals (NASDAQ: CRBP)
Nov 9, 2022
Corbus Pharmaceuticals (NASDAQ: CRBP)
Nov 9, 2022

Clinical-stage drug development company pioneering transformative medicines to treat inflammatory and fibrotic diseases by targeting the endocannabinoid system.

Nov 9, 2022
Cricket Health
Nov 9, 2022
Cricket Health
Nov 9, 2022

Comprehensive kidney care provider with a personalized, evidence-based approach to managing chronic kidney disease (CKD) and end-stage renal disease (ESRD).

Nov 9, 2022

If you would like to learn more about K2 HealthVentures, would like to suggest or submit an investment opportunity, or are interested in joining our team, please click here to email us.

Contact Us
Copyright© K2 HealthVentures™. All rights reserved.